Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma

Published:2020-04 Issue:4 Volume:18 Page:974-983
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Rich Nicole E.,Yang Ju Dong,Perumalswami Ponni V.,Alkhouri Naim,Jackson Whitney,Parikh Neehar D.,Mehta Neil,Salgia Reena,Duarte-Rojo Andres^ORCID,Kulik Laura,Rakoski Mina,Said Adnan,Oloruntoba Omobonike,Ioannou George N.,Hoteit Maarouf A.,Moon Andrew M.,Rangnekar Amol S.,Eswaran Sheila L.,Zheng Elizabeth,Jou Janice H.,Hanje James,Pillai Anjana,Hernaez Ruben^ORCID,Wong Robert,Scaglione Steven,Samant Hrishikesh,Kapuria Devika^ORCID,Chandna Shaun,Rosenblatt Russell^ORCID,Ajmera Veeral,Frenette Catherine T.,Satapathy Sanjaya K.,Mantry Parvez,Jalal Prasun,John Binu V.,Fix Oren K.,Leise Michael,Lindenmeyer Christina C.,Flores Avegail,Patel Nayan,Jiang Z. Gordon,Latt Nyan^ORCID,Dhanasekaran Renumathy,Odewole Mobolaji,Kagan Sofia^ORCID,Marrero Jorge A.,Singal Amit G.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Epidemiology of hepatocellular carcinoma: consider the population;Mittal;J Clin Gastroenterol,2013

2. Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer,2016

3. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation;Goldberg;Gastroenterology,2017

4. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States;Chhatwal;Ann Intern Med,2015

5. Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis;Foster;J Hepatol,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C型肝炎キャリア拾い上げにおいて，HCV抗体陽性者に対して残血清を用いたHCVコア抗原測定法併用の臨床的有用性;Kanzo;2023-12-01

2. Comparable Survival for Hepatitis C–Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status;Clinical Gastroenterology and Hepatology;2023-05

3. Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects;Frontiers in Oncology;2023-04-17

4. Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States;JAMA Network Open;2022-12-07

5. Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma;Cancer;2022-07-07